Skip to content

Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan Registry 2

Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan Registry 2

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02419794
Enrollment
2420
Registered
2015-04-17
Start date
2014-10-31
Completion date
2017-05-31
Last updated
2017-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Brief summary

The aim of this study is to clarify treatment status and clinical results of acute cerebral ischemia after approval of clot retriever in Japan, and also to obtain a basis for comparative studies.

Interventions

PROCEDUREendovascular treatment

endovascular treatment for acute ischemic stroke patients with large vessel occlusion

Sponsors

Hyogo Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients admitted from Oct. 1st 2014 to Sep. 30st 2016. * Patients who were 20 years and older admitted within 24 hours after onset. * The patients with large vessel occlusion (ICA, MCA, VA, BA, PCA). * Patients who did not fulfill the criteria of RESCUE-Japan RCT.

Exclusion criteria

・Patients who are considered inappropriate to participate in the study are excluded.

Design outcomes

Primary

MeasureTime frame
modified Rankin Scale (mRS) of 0-2 at 90 days (+/- 10 days) after onset90 days

Secondary

MeasureTime frame
All bleeding within 90 days (+/- 10 days) after onset90 days
Death within 90 days (+/- 10 day) after the onset90 days
modified Rankin Scale (mRS) of 0-1 at 90 days (+/- 10 days) after onset90 days
All intracranial hemorrhage within 90 days (+/- 10 days) after onset90 days
Symptomatic intracranial hemorrhage within 90 days (+/- 10 days) after onset90 days

Other

MeasureTime frame
Symptomatic intracranial hemorrhage within 72 hours (+/- 8 hours) after onset72 hours
Reccurrence of stroke within 90 days (+/- 10 days) after onset90 days

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026